Skip to content

Clinical trials

Phase 3 Weight Gain trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Weight Gain Phase: Phase 3 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20081
20112
20131
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Augusta University1
Eli Lilly and Company1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Lindner Center of HOPE1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Nationwide Children's Hospital1
Northwestern University1
University of Miami1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Weight Gain9
Obesity4
Diabetes Mellitus, Type 22
Bipolar Disorder1
Body Weight1
Gestational Weight Gain1
Hypertension1
Premature Birth1
Psychotic Disorders1
Schizophrenia1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.